Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy BioRestorative Therapies stock

Learn how to easily invest in BioRestorative Therapies stock.

BioRestorative Therapies, a Melvillve, NY-based company that develops stem cell therapies, has applied for listing on the Nasdaq under the ticker symbol "BRTX."

How to buy shares in BioRestorative Therapies

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BRTX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

BioRestorative Therapies stock price (NASDAQ: BRTX)

Use our graph to track the performance of BRTX stocks over time.

BioRestorative Therapies shares at a glance

Information last updated 2022-09-23.
Latest market close$2.83
52-week range$2.65 - $24.00
50-day moving average $3.12
200-day moving average $3.99
Wall St. target price$37.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-17.74

Buy BioRestorative Therapies shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy BioRestorative Therapies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

BioRestorative Therapies price performance over time

Historical closes compared with the close of $2.83 from 2022-09-28

1 week (2022-09-22) 2.83
1 month (2022-08-29) -16.76%
3 months (2022-06-29) -17.73%
6 months (2022-03-29) -44.07%
1 year (2021-09-29) 76,386.49%
2 years (2020-09-29) 15,364.48%
3 years (2019-09-27) 1,136.89%
5 years (2017-09-29) 3.25

BioRestorative Therapies financials

Revenue TTM $100,100
Gross profit TTM $46,000
Return on assets TTM -97.31%
Return on equity TTM -461.25%
Profit margin 0%
Book value $5.10
Market capitalisation $9.7 million

TTM: trailing 12 months

BioRestorative Therapies share dividends

We're not expecting BioRestorative Therapies to pay a dividend over the next 12 months.

Have BioRestorative Therapies's shares ever split?

BioRestorative Therapies's shares were split on a 1:4000 basis on 27 October 2021. So if you had owned 4000 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your BioRestorative Therapies shares – just the quantity. However, indirectly, the new 399900% higher share price could have impacted the market appetite for BioRestorative Therapies shares which in turn could have impacted BioRestorative Therapies's share price.

BioRestorative Therapies share price volatility

Over the last 12 months, BioRestorative Therapies's shares have ranged in value from as little as $2.65 up to $24. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BioRestorative Therapies's is 69.8909. This would suggest that BioRestorative Therapies's shares are significantly more volatile than the average for this exchange and represent a higher risk.

To put BioRestorative Therapies's beta into context you can compare it against those of similar companies.

BioRestorative Therapies overview

BioRestorative Therapies, Inc. , a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase 1 clinical trials for use in the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate that is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc.

Frequently asked questions

What percentage of BioRestorative Therapies is owned by insiders or institutions?
Currently 20.82% of BioRestorative Therapies shares are held by insiders and 20.32% by institutions.
How many people work for BioRestorative Therapies?
Latest data suggests 7 work at BioRestorative Therapies.
When does the fiscal year end for BioRestorative Therapies?
BioRestorative Therapies's fiscal year ends in December.
Where is BioRestorative Therapies based?
BioRestorative Therapies's address is: 40 Marcus Drive, Melville, NY, United States, 11747
What is BioRestorative Therapies's ISIN number?
BioRestorative Therapies's international securities identification number is: US0906556065
What is BioRestorative Therapies's CUSIP number?
BioRestorative Therapies's Committee on Uniform Securities Identification Procedures number is: 090655101

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site